US Bancorp’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $40.7K | Sell |
1,428
-17
| -1% | -$370 | ﹤0.01% | 2898 |
|
|
2026
Q1 | $25.1K | Buy |
1,445
+17
| +1% | +$322 | ﹤0.01% | 3011 |
|
|
2025
Q4 | $26.9K | Hold |
1,428
| – | – | ﹤0.01% | 2959 |
|
|
2025
Q3 | $20.8K | Sell |
1,428
-15,474
| -92% | -$221K | ﹤0.01% | 3053 |
|
|
2025
Q2 | $330K | Sell |
16,902
-1,501
| -8% | -$26.7K | ﹤0.01% | 1735 |
|
|
2025
Q1 | $327K | Buy |
18,403
+1,235
| +7% | +$26.6K | ﹤0.01% | 1727 |
|
|
2024
Q4 | $368K | Buy |
17,168
+15,464
| +908% | +$376K | ﹤0.01% | 1672 |
|
|
2024
Q3 | $53.2K | Sell |
1,704
-309
| -15% | -$7.69K | ﹤0.01% | 2704 |
|
|
2024
Q2 | $31.3K | Sell |
2,013
-1,023
| -34% | -$12.4K | ﹤0.01% | 2879 |
|
|
2024
Q1 | $32.2K | Sell |
3,036
-472
| -13% | -$4.72K | ﹤0.01% | 2902 |
|
|
2023
Q4 | $42.1K | Buy |
3,508
+1,716
| +96% | +$14.1K | ﹤0.01% | 2760 |
|
|
2023
Q3 | $12.5K | Hold |
1,792
| – | – | ﹤0.01% | 3081 |
|
|
2023
Q2 | $15.2K | Buy |
1,792
+1,416
| +377% | +$11.8K | ﹤0.01% | 3101 |
|
|
2023
Q1 | $3.44K | Sell |
376
-47
| -11% | -$601 | ﹤0.01% | 3636 |
|
|
2022
Q4 | $4.83K | Sell |
423
-2,035
| -83% | -$30.2K | ﹤0.01% | 3521 |
|
|
2022
Q3 | $42K | Sell |
2,458
-391
| -14% | -$8.39K | ﹤0.01% | 2638 |
|
|
2022
Q2 | $61K | Sell |
2,849
-5,681
| -67% | -$158K | ﹤0.01% | 2477 |
|
|
2022
Q1 | $315K | Buy |
8,530
+2,173
| +34% | +$84.7K | ﹤0.01% | 1740 |
|
|
2021
Q4 | $289K | Sell |
6,357
-23,243
| -79% | -$1.21M | ﹤0.01% | 1805 |
|
|
2021
Q3 | $1.88M | Buy |
29,600
+13,191
| +80% | +$1M | ﹤0.01% | 899 |
|
|
2021
Q2 | $1.5M | Buy |
16,409
+11,815
| +257% | +$939K | ﹤0.01% | 1004 |
|
|
2021
Q1 | $313K | Buy |
4,594
+4,158
| +954% | +$323K | ﹤0.01% | 1727 |
|
|
2020
Q4 | $32K | Hold |
436
| – | – | ﹤0.01% | 2690 |
|
|
2020
Q3 | $17K | Hold |
436
| – | – | ﹤0.01% | 2875 |
|
|
2020
Q2 | $15K | Buy |
+436
| New | +$12.4K | ﹤0.01% | 2931 |
|
|
2020
Q1 | – | Sell |
-56
| Closed | -$1K | – | 3685 |
|
|
2019
Q4 | $1K | Sell |
56
-472
| -89% | -$10.8K | ﹤0.01% | 3551 |
|
|
2019
Q3 | $12K | Sell |
528
-790
| -60% | -$21.9K | ﹤0.01% | 3000 |
|
|
2019
Q2 | $48K | Buy |
1,318
+123
| +10% | +$3.94K | ﹤0.01% | 2540 |
|
|
2019
Q1 | $38K | Buy |
1,195
+550
| +85% | +$16K | ﹤0.01% | 2610 |
|
|
2018
Q4 | $16K | Sell |
645
-1,034
| -62% | -$26.6K | ﹤0.01% | 2890 |
|
|
2018
Q3 | $49K | Buy |
1,679
+1,179
| +236% | +$22.1K | ﹤0.01% | 2561 |
|
|
2018
Q2 | $6K | Buy |
+500
| New | +$5.73K | ﹤0.01% | 3263 |
|
Other funds holding CDNA
DM
AIM
GS
US Bancorp's CDNA Position: Q2 2026 in Review
US Bancorp reduced its CareDx (CDNA) stake by 1.2% in Q2 2026, selling an estimated $370 and leaving 1,428 shares worth $40.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2898.
US Bancorp first reported a position in CDNA in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.88M in Q3 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- US Bancorp held 1,428 shares of CareDx worth $40.7K as of Q2 2026.
- US Bancorp sold 17 CareDx shares in Q2 2026, an estimated $370.
- CareDx made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2898 holding.
- US Bancorp first reported a position in CareDx in Q2 2018 and has held it in 32 quarters since.
- US Bancorp's CareDx position peaked at $1.88M in Q3 2021.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.